APA

Scott S. D., Fletcher M., Whitehouse H., Whitby L., Yuan C., Mazzucchelli S., Lin P., de Tute R., Dorwal P., Wallace P. K., Tembhare P., Arroz M., Snowden J. A., Chantry A. D. & Barnett D. (20200608). Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?. : Cytometry. Part B, Clinical cytometry.

Chicago

Scott Stuart D, Fletcher Matthew, Whitehouse Helen, Whitby Liam, Yuan Constance, Mazzucchelli Silvia, Lin Pei, de Tute Ruth, Dorwal Pranav, Wallace Paul K, Tembhare Prashant, Arroz Maria, Snowden John A, Chantry Andrew D and Barnett David. 20200608. Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?. : Cytometry. Part B, Clinical cytometry.

Harvard

Scott S. D., Fletcher M., Whitehouse H., Whitby L., Yuan C., Mazzucchelli S., Lin P., de Tute R., Dorwal P., Wallace P. K., Tembhare P., Arroz M., Snowden J. A., Chantry A. D. and Barnett D. (20200608). Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?. : Cytometry. Part B, Clinical cytometry.

MLA

Scott Stuart D, Fletcher Matthew, Whitehouse Helen, Whitby Liam, Yuan Constance, Mazzucchelli Silvia, Lin Pei, de Tute Ruth, Dorwal Pranav, Wallace Paul K, Tembhare Prashant, Arroz Maria, Snowden John A, Chantry Andrew D and Barnett David. Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?. : Cytometry. Part B, Clinical cytometry. 20200608.